Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sensus Healthcare (SRTS) EBIT Margin (2016 - 2025)

Sensus Healthcare has reported EBIT Margin over the past 10 years, most recently at 104.03% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 13823.0% year-over-year to 104.03%; the TTM value through Dec 2025 reached 7.35%, down 1188.0%, while the annual FY2025 figure was 7.35%, 1189.0% down from the prior year.
  • EBIT Margin for Q4 2025 was 104.03% at Sensus Healthcare, up from 37.32% in the prior quarter.
  • Over five years, EBIT Margin peaked at 104.03% in Q4 2025 and troughed at 86.09% in Q1 2023.
  • A 5-year average of 2.95% and a median of 10.22% in 2024 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: surged 21244bps in 2021 and later plummeted -12410bps in 2023.
  • Year by year, EBIT Margin stood at 40.84% in 2021, then fell by -22bps to 31.84% in 2022, then soared by 39bps to 44.38% in 2023, then plummeted by -177bps to 34.2% in 2024, then surged by 404bps to 104.03% in 2025.
  • Business Quant data shows EBIT Margin for SRTS at 104.03% in Q4 2025, 37.32% in Q3 2025, and 26.56% in Q2 2025.